The largest dental distributor in the US just installed a CEO from Thermo Fisher with a very specific plan to extract margin, and the stock is still sitting 55% below its DCF fair value like nothing has changed.
Stay with this, and you will see why two more undervalued names with real catalysts are sitting right next to it this week.
Global Focus (Sponsored)
When DeepSeek hit the headlines, Nvidia dropped nearly $600 billion in a single session.
Every investor felt it: What if China just won the AI race? But behind closed doors, America has already fired back — with a hidden project at the same Tennessee lab that built the atom bomb. 40,000 scientists.
A device trillions of times more powerful than anything China has built.
A $100 trillion AI reset on the way.
Billion-dollar money manager Louis Navellier has identified the one stock that wins this arms race.
Click here for the name and ticker — free.
Agricultural Equipment
Ag Equipment Giant Sits 37% Below Analyst Consensus After a Two-Year Industry Downturn
AGCO Corporation (NYSE: AGCO), maker of Fendt, Massey Ferguson, and Challenger equipment, trades around $72 against an analyst consensus target of $113.75, a 37% discount, with DCF fair value coming in even higher. The stock got crushed through the 2024-2025 ag equipment downturn as farm incomes softened and orders slowed. That is a cycle, not a structural problem.
AGCO has been using the downturn to cut costs, reduce inventory, and sharpen its precision agriculture platform through Fendt. Q1 2026 earnings beat estimates, which tells you execution is holding up even when the macro is not cooperating.
At roughly 10x forward earnings against an industry that re-rates to 15x at cycle inflection, the gap is wide enough to take seriously.
Earnings Beat in Q1 Confirms the Business Is Holding Through the Trough
Beating estimates during a down cycle tells you management is executing rather than waiting for conditions to rescue them. That kind of discipline at the bottom is what sets up a meaningful re-rating when demand turns.
Fendt's Premium Positioning Protects Margins When the Cycle Gets Ugly
Fendt commands premium pricing in global ag markets that the broader equipment cycle cannot fully erase. That structural advantage keeps gross margins more resilient than the revenue decline suggests, and it is exactly what the $113.75 consensus target is anchored to.
Healthcare Distribution
Dental Distributor Gets a New CEO, a $200M Profit Plan, and the Stock Barely Moved
Henry Schein (NASDAQ: HSIC), the largest dental and medical products distributor in the US, trades around $74 against a DCF fair value of $130, a 55% discount, and well below a TIKR model target of $109.94. The stock has been roughly flat year to date despite two developments that meaningfully change the forward earnings picture.
Frederick Lowery took over as CEO in March 2026 with a Value Creation Plan targeting over $200 million in operating profit improvements through pricing and back-office consolidation. KKR holds a strategic partnership with the right to increase its stake to 19.9%, which adds a layer of institutional conviction you do not get from most turnaround stories.
The forward PE sits at 14-15x while historical Schein trades closer to 18x. That gap is not subtle.
New CEO With a Real Distribution Track Record
Lowery ran distribution at Thermo Fisher, which means the $200 million profit target is not an aspiration. It is the kind of specific operational number someone puts in writing because they have extracted that kind of margin from a similar business before.
KKR's 19.9% Ownership Right
When KKR negotiates the right to own nearly a fifth of a business, the institutional read on intrinsic value is clearly sitting well above the current stock price. That conviction, alongside new leadership with a defined execution plan, is the combination worth getting in front of.
IPO Filing Shock (Sponsored)
It was supposed to be confidential...
But it's become the worst-kept secret on Wall Street.
Right now, 21 banks are lining up to underwrite the $1.75 TRILLION deal - JPMorgan, Goldman Sachs, Morgan Stanley.
June is the target date for launch...
That gives everyday Americans a small window to get positioned before Wall Street insiders gobble up all the profits.
Social Media and AI
Snap (NYSE: SNAP) trades around $6 against an Alpha Spread intrinsic value of $9.81, a 38% discount, with analyst targets clustered at $7 to $8 and a $500 million buyback running. The bear narrative on ad cycles and Meta competition has been priced in long enough that the setup has quietly shifted.
Snapchat+ subscriptions have been growing consistently, AI-driven targeting has been lifting per-user revenue, and AR commerce tools are rolling out to creators. The business is still loss-making with a 2026 EPS forecast at negative $0.10, so the cheap DCF is not yet an earnings story. The buyback at these levels is the clearest signal management is sending about where they think fair value sits.
If Q2 ad metrics confirm Q1, the multiple has real room to move from a 38% discount base.
Snapchat Plus Growth and ARPU Improvements
Subscription growth and AI-driven targeting improvements are reducing reliance on standard programmatic advertising in a measurable way. That shift toward higher-quality, more defensible revenue is what the DCF models are picking up on, even while the earnings line is still negative.
A $500M Buyback on a $9B Market Cap at $6 Per Share
You do not run a buyback equal to 5% of your market cap at a 38% discount to intrinsic value without meaning it. That is management putting the balance sheet behind a view that the current price is significantly wrong.
Actionable Picks This Week
Mosaic Company (NYSE: MOS) is sitting at a 45% discount to DCF fair value around $22 with a 4.11% dividend yield and an RBC Outperform upgrade, specifically citing the current phosphate margin depression as a cycle, not a structural break.
Phosphate pricing has stabilized, Indian monsoon dynamics plus tight Chinese export quotas are setting up a tighter supply picture into late 2026, and insiders have not been selling. You are buying a globally essential crop nutrient business at what RBC is calling a trough-cycle entry with a dividend that pays you while you wait.
The risk is that sulfur cost pressure running to $540 per ton in Q2 extends margin pain longer than the recovery thesis requires.
PVH Corp (NYSE: PVH) reports earnings this week, with the bar sitting very low and the stock trading around 7x forward earnings against mid-teens peers like Tapestry and Ralph Lauren.
Calvin Klein and Tommy Hilfiger have been under pressure from FX and promotional activity, but management has been aggressive on cost reduction and SKU rationalization in a way that tends to show up in margins before revenue recovers.
Any sign of stabilization on the call is a positive signal from a stock that has already priced in a lot of bad news. The risk is that macro deterioration hits the brand portfolio harder than the cost cuts can offset.
HF Sinclair (NYSE: DINO) is another Morningstar undervalued name sitting at a 40% to 51% discount to DCF fair value with a dividend yield above 3% and 39 consecutive years of payments behind it.
Crack spreads have widened on Iran-related supply disruption, the renewable diesel segment is turning the corner, and management has been steadily buying back stock. You get a refining and midstream hybrid with optionality on sustained energy pricing strength and a capital return story that does not need a perfect macro to keep delivering.
The risk is that a ceasefire deal reopens Hormuz faster than expected and eliminates the geopolitical bid in crack spreads.
Hidden Opportunity (Sponsored)
SpaceX may be heading toward a historic IPO.
But Louis Navellier says the better opportunity could be a little-known AI hardware firm Elon Musk used to help power his massive supercomputer.
Now, major tech giants are using similar technology as AI spending surges.
And because this company is reportedly 39X smaller than SpaceX, investors may still have time before Wall Street catches on.
Fast Movers to Watch
Kilroy Realty (NYSE: KRC) is a West Coast office REIT trading at a deep discount to NAV with a Morningstar 4-star rating and a life-science and tech-tenant mix that genuinely differentiates it from generic office exposure.
The dividend has held through the office headwinds, and occupancy stabilization in the upcoming results is the catalyst worth watching. This is a name where the market has thrown the baby out with the bathwater on office real estate, and the fundamentals are better than the label suggests.Healthpeak Properties (NYSE: DOC) is a healthcare REIT with a 7.4% dividend yield, raised 2026 guidance after Q1, and an active capital recycling program including $714 million in senior housing additions and a $312 million JV buyout with Blackstone.
The demographic tailwinds behind senior housing and medical offices are structural rather than cyclical, and the multiple still reflects a market treating it like any other rate-sensitive REIT. That disconnect between the business mix quality and the valuation is what keeps this on the radar.MarketAxess Holdings (NASDAQ: MKTX) is a fixed-income electronic trading platform sitting well below its historical multiple, while the equity-market rally has captured all the attention.
As bond trading volumes normalize and institutional adoption of electronic fixed-income continues building, the operating leverage in this business becomes increasingly visible. The next earnings call commentary on institutional client adoption is the signal worth watching.
What's your biggest challenge when trying to find undervalued stocks?
Everything Else
Starbucks reported rising afternoon store traffic between 3 p.m. and 5 p.m., with shares up 21% year to date as CEO Brian Niccol’s turnaround plan gains traction.
Costco reported Q3 fiscal 2026 net sales of $69.15 billion, up 11.6% year over year, with EPS of $4.93, beating estimates, and worldwide membership renewal rates holding at 89.7%.
Core PCE inflation for April 2026 rose 3.4% year over year, up from 3.2% in March, exceeding expectations and complicating the Federal Reserve’s path toward rate cuts.
WTI crude oil steadied near $99 as markets awaited progress on a possible U.S.-Iran ceasefire that could reopen the Strait of Hormuz and ease global supply concerns.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any [blank] stocks you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge
